Indefinite Delivery Contract 266030065

The University of Texas Medical Branch at Galveston (UTMB) holds a single award indefinite delivery contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $67.4 million IDC, awarded on September 15, 2003, provides NIAID with a flexible contracting mechanism to efficiently order a range of preclinical research and development services from UTMB to support the evaluation of candidate therapeutics, vaccines, and diagnostics against various infectious disease pathogens. Task orders under this IDC, valued at over $64 million to date, cover activities such as animal model development, testing of medical countermeasures, and production of specialized reagents. The work is primarily performed at UTMB's facilities in Galveston, Texas and does not utilize any small business or other set-aside designations. As a state-run educational institution with deep expertise in infectious disease research, UTMB leverages its specialized biosafety capabilities and extensive experience supporting federal biomedical research to rapidly respond to NIAID's evolving needs in areas like emerging infectious diseases and antimicrobial resistance.

The University of Texas System, of which UTMB is a component, also holds numerous other federal contract and grant awards across its various institutions. These fund a broad spectrum of research, development, testing, and professional services in domains such as medicine, engineering, natural sciences, and social sciences. UT System institutions frequently collaborate with other universities, national laboratories, and industry partners as both prime recipients and subrecipients on these federally-funded projects, which are awarded by agencies including the Department of Defense, Department of Energy, National Aeronautics and Space Administration, and National Institutes of Health.